In breast cancer, since the activation of AKT and the subsequent activation of HSF1 by p-AKT shortens the metastatic intervals of tumor cells, inhibition of the AKT/HSF1 signaling axis resulted in the reduced number of metastatic breast cancer cells and cancer stem cells [80]. Here, HSF1 is linked to breast carcinoma.